XTX Topco’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.37M Buy
12,097
+7,612
+170% +$4.27M 0.08% 273
2026
Q1
$2.52M Buy
+4,485
New +$2.88M 0.04% 672
2025
Q2
Sell
-3,126
Closed -$1.31M 2726
2025
Q1
$1.31M Buy
+3,126
New +$1.36M 0.07% 402
2024
Q2
Sell
-426
Closed -$230K 2136
2024
Q1
$230K Sell
426
-1,146
-73% -$626K 0.03% 1067
2023
Q4
$873K Sell
1,572
-5,115
-76% -$2.4M 0.19% 46
2023
Q3
$2.92M Buy
+6,687
New +$3.33M 0.5% 3
2023
Q2
Sell
-483
Closed -$242K 1597
2023
Q1
$242K Sell
483
-2,831
-85% -$1.35M 0.05% 808
2022
Q4
$1.35M Buy
+3,314
New +$1.29M 0.29% 42
2022
Q2
Sell
-1,081
Closed -$591K 966
2022
Q1
$591K Buy
1,081
+578
+115% +$304K 0.26% 109
2021
Q4
$331K Buy
503
+82
+19% +$51.5K 0.19% 163
2021
Q3
$262K Buy
+421
New +$283K 0.09% 389

Other funds holding IDXX

XTX Topco's IDXX Position: Q2 2026 in Review

XTX Topco increased its Idexx Laboratories (IDXX) stake by 170% in Q2 2026, buying an estimated $4.27M and bringing the position to 12,097 shares worth $6.37M. The position accounts for 0.08% of the portfolio, ranked #273.

XTX Topco first reported a position in IDXX in Q3 2021 and has held it in 11 quarters since. 1,300 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • XTX Topco held 12,097 shares of Idexx Laboratories worth $6.37M as of Q2 2026.
  • XTX Topco bought 7,612 Idexx Laboratories shares in Q2 2026, an estimated $4.27M.
  • Idexx Laboratories made up 0.08% of XTX Topco's portfolio in Q2 2026, its #273 holding.
  • XTX Topco first reported a position in Idexx Laboratories in Q3 2021 and has held it in 11 quarters since.
  • 1,300 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.